XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.23.3

Income Per Share and Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share And Stockholders Equity [Abstract] |
Income Per Share and Stockholders' Equity | Income Per Share and Stockholders’ Equity The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows (dollars in thousands, except share and per share data):
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Basic Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 190,553 |  |  | $ | 446,639 |  |  | $ | 508,849 |  |  | $ | 1,326,258 |
Weighted average shares outstanding for basic income per share | 307,854,518 |  |  | 319,827,769 |  |  | 309,716,456 |  |  | 325,705,500 |
Basic income per share attributable to CBRE Group, Inc. stockholders | $ | 0.62 |  |  | $ | 1.40 |  |  | $ | 1.64 |  |  | $ | 4.07 |
Diluted Income Per Share |  |  |  |  |  |  |
Net income attributable to CBRE Group, Inc. stockholders | $ | 190,553 |  |  | $ | 446,639 |  |  | $ | 508,849 |  |  | $ | 1,326,258 |
Weighted average shares outstanding for basic income per share | 307,854,518 |  |  | 319,827,769 |  |  | 309,716,456 |  |  | 325,705,500 |
Dilutive effect of contingently issuable shares | 4,366,615 |  |  | 4,914,815 |  |  | 4,228,399 |  |  | 4,852,814 |
Weighted average shares outstanding for diluted income per share | 312,221,133 |  |  | 324,742,584 |  |  | 313,944,855 |  |  | 330,558,314 |
Diluted income per share attributable to CBRE Group, Inc. stockholders | $ | 0.61 |  |  | $ | 1.38 |  |  | $ | 1.62 |  |  | $ | 4.01 |
For the three and nine months ended September 30, 2023, 326,762 and 345,108, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. For the three and nine months ended September 30, 2022, 1,506,140 and 1,369,162, respectively, of contingently issuable shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive effect. On November 19, 2021, our board of directors authorized a program for the repurchase of up to $2.0 billion of our Class A common stock over five years (the 2021 program). On August 18, 2022, our board of directors authorized an additional $2.0 billion, bringing the total authorized repurchase amount under this program to a total of $4.0 billion. During the three months ended September 30, 2023, we repurchased 6,213,921 shares of our common stock with an average price of $83.03 per share using cash on hand for an aggregate of $515.9 million under the 2021 program. During the nine months ended September 30, 2023, we repurchased 7,582,094 shares of our common stock with an average price of $83.11 per share using cash on hand for an aggregate of $630.2 million under the 2021 program. As of September 30, 2023, we had approximately $1.5 billion of capacity remaining under the 2021 program. During the three months ended September 30, 2022, we repurchased 5,094,577 shares of our common stock using cash on hand for an aggregate of $408.3 million. During the nine months ended September 30, 2022, we repurchased 16,783,086 shares of our common stock using cash on hand for an aggregate of $1.4 billion.

X
- Definition Earnings per share and stockholders' equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityAbstract
Namespace Prefix: | cbre_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Earnings per share and stockholder's equity. + References No definition available. + Details
Name: | cbre_EarningsPerShareAndStockholdersEquityTextBlock
Namespace Prefix: | cbre_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration